The company expired its plan on May 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.11 CNY | +0.33% | +1.79% | -26.89% |
Jun. 03 | Xintian Pharmaceutical Gets Nod to Trial Chronic Non-Bacterial Prostatitis Drug; Shares Down 3% | MT |
May. 14 | Guiyang Xintian Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.89% | 272M | |
+14.66% | 9.25B | |
+42.06% | 4.45B | |
-22.01% | 4.43B | |
+8.28% | 4.03B | |
+10.13% | 2.24B | |
-26.61% | 2.18B | |
+11.64% | 2.02B | |
-42.69% | 1.79B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has expired with 8,806,030 shares, representing 3.81% for CNY 75.3 million.